QIAGEN generated about $2.09 billion of 2025 revenue, $466 million of operating income and $654 million of operating cash flow. The thesis depends on sample-to-insight diagnostics demand, consumables quality, regional exposure, capital discipline and debt-funded portfolio investment.
QIAGEN: a diagnostics platform where cash flow has to fund the next growth leg
NYSEQGENCoverage BootstrapQIAGEN N.V.
Thesis summary
QIAGEN generated about $2.09 billion of 2025 revenue, $466 million of operating income and $654 million of operating cash flow. The thesis depends on sample-to-insight diagnostics demand, consumables quality, regional exposure, capital discipline and debt-funded portfolio investment.
View article
Discuss the thesis
0 commentsCommenting requires active membershipBecome a member
Attack the thesis, not the person.Add evidence when challenging claims.No pump, spam, or low-effort comments.
No comments yet. Start the discussion with evidence, a question, or a bear case.